G protein-coupled receptor 151 regulates glucose metabolism and hepatic gluconeogenesis
Preprint
Abstract
Human genetics has been instrumental in identification of genetic variants linked to type 2 diabetes (T2D). Recently a rare, putative loss-of-function mutation in the orphan G-protein coupled receptor 151 ( GPR151 ) was found to be associated with lower odds ratio for T2D, but the mechanism behind this association has remained elusive. Here for the first time we show that Gpr151 is a fasting- and glucagon-responsive hepatic gene which regulates hepatic gluconeogenesis. Gpr151 ablation in mice leads to suppression of hepatic gluconeogenesis genes and reduced hepatic glucose production in response to pyruvate. Importantly, the restoration of hepatic Gpr151 levels in the Gpr151 knockout mice reverses the reduced hepatic glucose production. Our findings establish a previously unknown role of Gpr151 in the liver and provides an explanation to the lowered T2D risk in individuals with nonsynonymous mutations in GPR151 . This study highlights the therapeutic potential of targeting GPR151 for treatment of metabolic disease.Keywords
All Related Versions
- Published version: Nature Communications, 13 (1), 1.
This publication has 44 references indexed in Scilit:
- Dynamic regulation of genome-wide pre-mRNA splicing and stress tolerance by the Sm-like protein LSm5 in ArabidopsisGenome Biology, 2014
- Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMPNature, 2013
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- Anatomical Profiling of G Protein-Coupled Receptor ExpressionCell, 2008
- The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signalingNature Immunology, 2008
- Endocrine Regulation of the Fasting Response by PPARα-Mediated Induction of Fibroblast Growth Factor 21Cell Metabolism, 2007
- Adipocytes as regulators of energy balance and glucose homeostasisNature, 2006
- Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interactionNature, 2003
- Impaired Glucose Transport as a Cause of Decreased Insulin-Stimulated Muscle Glycogen Synthesis in Type 2 DiabetesNew England Journal of Medicine, 1999
- Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus.Journal of Clinical Investigation, 1998